Drug recall D-0556-2024

Class III Ongoing reported Jun 26, 2024

Product

Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10

Reason for recall

Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

Lots and codes

Lot #: 3EF22003, Exp 6/30/2025

Recall details

Recalling firm
Eugia US LLC, East Windsor, NJ
Quantity
15,500 single dose vials
Distribution
USA nationwide.
Type
Voluntary: Firm initiated
Recall initiated
May 22, 2024

Related products